Summary
The product SUSTANON 250 mg, manufactured by Axle Labs, underwent independent testing to verify its authenticity and potency. The sample, identified by batch number 010, was submitted by Axle Labs and analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control. The analysis measured the total concentration of testosterone esters at 265.45 mg/ml, exceeding the labeled claim of 250 mg/ml.
The testing process began on 16 September 2024, with the sample received on 18 September 2024, and analysis completed on 24 September 2024. While the results confirm the presence of the expected testosterone esters, the higher-than-labeled concentration indicates potential inconsistencies in formulation. Independent third-party testing remains critical to validate these findings comprehensively. This report serves as an educational resource to promote harm reduction and informed decision-making.
Detailed Report
Product Overview
- Manufacturer: Axle Labs
- Product Name: SUSTANON 250 mg
- Active Ingredient: Testosterone Esters
- Batch Number: 010
- Expiration Date: Not provided
- Delivery Method: Injectable
Sample Acquisition and Testing
- Task Number: #49104
- Testing Ordered: 16 September 2024
- Sample Received: 18 September 2024
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: Axle Labs (Manufacturer)
- Analysis Paid For By: Axle Labs (Manufacturer)
Testing Results
- Specification: 250 mg/ml (as stated on the label)
- Measured Concentration: 265.45 mg/ml
- Accuracy: 106.18% (6.18% above the label claim)
- Purity: Not specified
- Additional Notes:
- No Guaiacol detected
- Testosterone breakdown:
- Testosterone Propionate: 29.40 mg/ml
- Testosterone Phenylpropionate: 51.60 mg/ml
- Testosterone Isocaproate: 59.54 mg/ml
- Testosterone Decanoate: 124.91 mg/ml
Verification Details
Verification URL: https://janoshik.com/tests/49104_7A24U16CC231
Evaluation of Manufacturer-Submitted Testing
This analysis highlights that the SUSTANON 250 mg sample slightly exceeds the expected dosage, with a measured total concentration of 265.45 mg/ml instead of 250 mg/ml. While this indicates a potent formulation, discrepancies in testosterone ester concentrations necessitate further scrutiny. Since Axle Labs submitted and funded the test, careful evaluation is needed to assess consistency across different batches. While Janoshik Analytical is recognized for its transparency and rigorous testing protocols, these findings would benefit from independent validation through third-party testing.
Conclusion
The analysis confirms that SUSTANON 250 mg slightly exceeds the labeled concentration, measuring 265.45 mg/ml. While this suggests a potent product, variations in individual testosterone ester concentrations highlight potential formulation inconsistencies. Further testing across different batches is recommended to ensure uniformity. This report is provided to support educational and harm reduction efforts, helping consumers make informed choices regarding performance-enhancing compounds.
Disclaimer
This report is published for educational and harm reduction purposes. Manufacturer-submitted testing may involve inherent biases; however, it can still provide useful data when critically assessed alongside third-party or independent results. Readers are encouraged to use this information responsibly.
